Showing results (201-210 of 1,545) with videos related to
Sort By:
Pageof 155
Gene Therapy|May 9, 2000
Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vectorC Hiller, S Wittmann, S Slavin, et al.Experimental Hematology|December 1, 1995
Inhibition of leukemic cell proliferation by one or more factors released from splenic BCL1 cellsH Bessler, J Hart, S Slavin, et al.Cancer Immunology, Immunotherapy : CII|October 1, 1995
Induction of tumor immunity by intact irradiated leukemic B cells (BCL1) bearing a tumor-associated cell-surface idiotype and the costimulatory B7 moleculeS Morecki, S Levi, Y Puyesky, et al.Bone Marrow Transplantation|July 1, 1990
IL-2 activated cell-mediated immunotherapy: control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2S Slavin, A Ackerstein, E Kedar, et al.Bone Marrow Transplantation|December 1, 1987
Monoclonal rat anti-human lymphocyte antibody Campath-1 binds to T and B lymphocytes but effectively lyses only T cellsY Gazitt, R Or, M Mumcuoglu, et al.Bone Marrow Transplantation|January 1, 1992
Clinical application of intrauterine bone marrow transplantation for treatment of genetic diseases--feasibility studiesS Slavin, E Naparstek, M Ziegler, et al.Bone Marrow Transplantation|April 13, 2004
Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapyL Weiss, S Reich, O Mandelboim, et al.Bone Marrow Transplantation|March 1, 1989
Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantationM Mumcuoglu, L Weiss, J Spivak, et al.The American Journal of Managed Care|February 8, 2000
Attitudes toward managed care and cost containment among primary care trainees at 3 training sitesS A Skootsky, S Slavin, M S WilkesExperimental Hematology|January 1, 1993
Investigations on the role of inflammatory and anti-inflammatory agents on the treatment of murine B cell leukemia by recombinant human interleukin-2U Vourka-Karussis, F Levi-Schaffer, S SlavinPageof 155